Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $205 Million Series A Financing Oct 01, 2025
Fortress Biotech to Present at the H.C. Wainwright 27th Annual Global Investment Conference Sep 02, 2025
Fortress Biotech Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights Aug 14, 2025
Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights Aug 12, 2025
Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025 Aug 05, 2025
